Abstract
The treatment of renal cancer has changed in the last decades with an increase in application of conservative surgery such as partial nephrectomy (PN) in order to achieve an optimal oncological outcome with the maximum preservation of renal function. The indication for PN is mandatory in case of bilateral tumors or in case of impaired renal function. Renal artery (RA) aneurysm (RAA) is a rare occurrence, and its treatment could be radiological or surgical according to the anatomy of the aneurysm and the clinical characteristics of the patients. Here, we report a case of simultaneous ipsilateral occurrence of renal cancer and RAA in a patient with bilateral renal masses, treated with 1 surgical procedure with good functional and oncological outcomes. This rare occurrence must be known by surgeons treating renal cancers, and it is possible to perform the 2 procedures in 1 surgical step.
Journal Section:
Case Report
References
1.
Klatte
T
, Wunderlich
H
, Patard
JJ
, Kleid
MD
, Lam
JS
, Junker
K
, . Clinicopathological features and prognosis of synchronous bilateral renal cell carcinoma: an international multicentre experience
. BJU Int
. 2007
;100
(1
):21
–5
.2.
Blute
ML
, Itano
NB
, Cheville
JC
, Weaver
AL
, Lohse
CM
, Zincke
H
, . The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma
. J Urol
. 2003
;169
(4
):1276
–81
.3.
Henke
PK
, Cardneau
JD
, Welling
TH
, Upchurch
GR
Jr, Wakefield
TW
, Jacobs
LA
, . Renal artery aneurysms: a 35-year clinical experience with 252 aneurysms in 168 patients
. Ann Surg
. 2001 Oct
;234
(4
):454
–3
. discussion 462–3
.http://dx.doi.org/10.1097/00000658-200110000-00005.4.
Hafez
KS
, Krishnamurthi
V
, Campbell
SC
, Novick
AC
. Contemporary management of renal cell carcinoma with coexistent renal artery disease: update of the cleveland clinic experience
. Urology
. 2000 Sep 1
;56
(3
):382
–6
.5.
Selli
C
, Carini
M
, Turini
D
, Schifano
A
. Renal cell carcinoma associated with renal artery aneurysm. Report of two cases
. Urol Int
. 1983
;38
(6
):374
–7
.6.
Takamizawa
A
, Hirano
J
, Watanabe
H
, Ishigohka
M
, Kawamura
S
. Conservative surgery of renal cell carcinoma associated with renal (artery) aneurysm in solitary kidney: a case report
. Nihon Hinyokika Gakkai Zasshi
. 1989
;80
:274
–8
.7.
Yazawa
K
, Nishimura
K
, Miura
H
, Honda
M
, Fujioka
H
. [Renal cell carcinoma associated with renal artery aneurysm]
. Hinyokika Kiyo
. 1997
;43
(5
):343
–5
.8.
Subramonian
K
, Weston
PM
, Curley
P
. Multifocal renal cancer associated with renal artery aneurysm and a unique genetic change
. Br J Urol
. 1998
;82
(5
):761
–2
.9.
Casillas
RA
, Romero
L
, Virgilio
C
. Coexisting renal cell carcinoma and renal artery aneurysm
. Ann Vasc Surg
. 2002
;16
(3
):353
.10.
Wang
Z
, Xiong
W
, Pan
C
, Zhu
L
, Wang
P
, Wang
X
, . Coexisting renal cell carcinoma and renal artery aneurysm: a case report and literature review
. Exp Ther Med
. 2015
;9
(6
):2356
–8
.11.
Abreu
A
, Medina
LG
, Chopra
S
, Gill
K
, Cacciamani
GE
, Azhar
RA
, . Robotic renal artery aneurysm repair
. Eur Urol
. 2020 Jul
;78
(1
):87
–96
.© 2021 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2021
You do not currently have access to this content.
